Shire files patent infringement lawsuits against Sandoz, Amneal
VYVANSE is a prescription medicine for the treatment of attention deficit hyperactivity disorder (ADHD). Efficacy was based on two controlled trials in children aged six to 12 and
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
The agreement will provide the Rochester-based global eye health company with manufacturing capabilities in India to accelerate the launch of new prescription and over-the-counter ophthalmic drops including Moxisurge,
Quotient Bioresearch provides early stage and specialist drug development services to pharmaceutical, biotechnology and medical device clients worldwide. Peptides which have been site-specifically labeled with tritium are ideal